Table 1.
Groups | Weight (g) | |||
---|---|---|---|---|
0 Weeks | 4 Weeks | 8 Weeks | Weight Gain | |
Control | 120.04 ± 4.66a | 303.62 ± 10.43a | 371.21 ± 14.01a | 245.13 ± 9.00a |
Model | 125.19 ± 4.79a | 267.32 ± 5.62b | 308.56 ± 4.58e | 189.36 ± 8.33f |
HCaCO3 | 120.39 ± 9.22a | 269.63 ± 14.27b | 326.33 ± 19.47bcd | 211.42 ± 9.63bcd |
HGCa | 122.70 ± 2.19a | 271.54 ± 13.35b | 331.92 ± 11.43bc | 221.79 ± 10.96bc |
LCPPH + LCaCO3 | 122.443 ± 4.75a | 266.95 ± 11.27b | 320.97 ± 14.36cde | 196.53 ± 11.53ef |
MCPPH + MCaCO3 | 119.72 ± 5.43a | 271.54 ± 17.60b | 328.01 ± 24.35bcd | 208.23 ± 21.50cde |
HCPPH + HCaCO3 | 123.94 ± 4.76a | 269.85 ± 12.52b | 333.47 ± 17.22bc | 214.70 ± 11.34bcd |
LCPPH-Ca | 123.34 ± 4.49a | 267.35 ± 9.50b | 325.72 ± 20.89bcd | 202.38 ± 17.97def |
MCPPH-Ca | 121.65 ± 4.63a | 269.20 ± 6.67b | 332.21 ± 11.45bc | 204.33 ± 15.22de |
HCPPH-Ca | 121.85 ± 7.19a | 270.62 ± 13.87b | 340.02 ± 20.01a | 223.41 ± 13.03b |
Note: control, normal group; model, low calcium group; HCaCO3, high dosage of CaCO3 group; HGCa, high dosage of calcium gluconate group; LCPPH + LCaCO3, low dosage of CPPH supplemented with low dosage of CaCO3 group; MCPPH + MCaCO3, model dosage of CPPH supplemented with model dosage of CaCO3 group; HCPPH + HCaCO3, high dosage of CPPH supplemented with high dosage of CaCO3 group; LCPPH-Ca, low dosage of CPPH-Ca group; MCPPH-Ca, model dosage of CPPH-Ca group; HCPPH-Ca, high dosage of CPPH-Ca group. Data are expressed as the mean ± SD (n = 10). One-way ANOVA with Tukey’s test. Different letters indicate significant effect with p < 0.05.